COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.


Click here to see the full list of Cantor's publications via PubMed.

Rothmeier A, Marchese P, Langer F Kamikubo T Scharrner F, Cantor JM, Ginsberg MH, Ruggeri Z, and Ruf W. Tissue factor protherombotic activity is regulated by integrin-arf6 trafficking.  Arteriosclerosis, Thrombosis, and Vascular Biology.  2017, In press.

Lagarrigue F, Gertler FB, Ginsberg MH, and Cantor JM.  Loss of T cell RIAM Disrupts Immunological Synapses and Prevents Immune-mediated Diabetes.  J Immunol., 2017, May 1; 198(9):2410-3415; PMID: 28348273.

Bajaj J, Konuma T,  Lytle NK, Kwon HY, Rizzieri D, Chuah C, Oehler VG, Ablack J, Cantor  JM, Van der Horst EH, Ginsberg MH and Reya T. CD98-mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.  Cancer Cell.  2016 Nov 14;30(5):792-805; PMID: 27908736.

Liao, Z and Cantor JM. Endothelial Cells Require CD98 for Efficient Angiogenesis. Atherosclerosis, Thrombosis, and Vascular Biology.  2016 Nov;36(11):2163-2166; PMID: 27687603.

Abplanalp WT, Conklin DJ, Cantor JM, Ginsberg MH, Bhatnagar A, and O’Toole TE. Enhanced integrin a4β1-mediated adhesion contributes to a mobilization defect of endothelial progenitor cells in diabetes. Diabetes. 2016 Aug. 5;  PMID: 27495221.

Cantor JM. Homing Improvement: Boosting T cell Trafficking for Cancer Immunotherapy. In Donnadieu E (Ed), Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy, Springer Science and Business Media, 2016, 9:127-162.

Ablack JN, Metz PJ, Chang JT, Cantor JM, and Ginsberg MH. Ubiquitylation of CD98 limits cell proliferation and clonal expansion. J Cell Sci 2015 128: 4273-4278; PMID: 26493331.

Cantor JM, Rose DM, Slepak M, and Ginsberg MH. Fine-Tuning Tumor Immunity With Integrin Trans-regulation. Cancer Immunol Res. 2015 Jan 19;  PMID: 25600437.

Hayes GM, Chinn L, Cantor JM, Cairns B, Levashova Z, Tran H, Velilla T, Duey D, Lippincott J, Zachwieja J, Ginsberg MH, Van der Horst HE. Anti-tumor activity of an anti-CD98 antibody. Int J Cancer. 2014 Dec 29;  PMID: 25556716.

Liao Z, Kato H, Pandey M, Cantor JM, Ablooglu A.J, and Ginsberg MH, Shattil SJ. Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor. Blood. 2015 Jan 13;  PMID: 25587038.

Cantor JM. CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis. J Neuroimmunol. 2014 Sep 15;274(1-2):230-3;  PMID: 25002078.

Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci. 2012 Mar 15;125(Pt 6):1373-82.

Cantor JM, Slepak M, Ege N, Chang JT, Ginsberg MH. Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. J Immunol. 2011 Jul 15;187(2):851-60.

Cantor J, Browne CD, Ruppert R, Féral CC, Fässler R, Rickert RC, Ginsberg MH. CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nat Immunol. 2009 Apr;10(4):412-9.

Cantor J, Ginsberg MH, Rose DM. Integrin-associated proteins as potential therapeutic targets. Immunol Rev. 2008 Jun;223:236-51.

Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J Immunol. 2007 Nov 1;179(9):5760-7.

Cantor J, Haskins K. Interactions of macrophages and T cells in autoimmune diabetes. Drug Discovery Today: Disease Mechanisms. 2006 October 31; 3(3):381-385.

Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol. 2005 Dec 1;175(11):7738-45.